Intracranial Atherosclerosis Clinical Trial
— AICADOfficial title:
Asymptomatic Intracranial Atherosclerotic Disease: Prevalence, Clinical and Lifestyle Determinants in Urban Pakistan
Verified date | February 2014 |
Source | Aga Khan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Pakistan: Research Ethics Committee |
Study type | Observational |
The incidence of stroke has increased by 100% in the last four decades in developing countries like Pakistan. Intracranial atherosclerotic disease (ICAD) is the most frequent causative subtype of ischemic stroke in the world including Pakistan. ICAD is progressive narrowing of the arteries at the base of the brain due to atherosclerosis. After a stroke from ICAD, recurrence rate is highest in any sub-type of stroke, up to 28% with limited therapeutic options. Therefore, it is imperative to delineate the determinants of asymptomatic ICAD prior to stroke. Investigators hypothesized that there is at least a 20% difference in the proportion of clinical, life-style (dietary, physical activity, obesity, smoking and stress/depression), and socio-economic predictors of asymptomatic ICAD than those with no ICAD.
Status | Completed |
Enrollment | 200 |
Est. completion date | June 2013 |
Est. primary completion date | June 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adult Pakistani men and women = 18years getting MRI brain for any indication other than stroke. - Permanent residents of Pakistan for at least 1 year. - No prior history of stroke which was confirmed by screening with Questionnaire for verifying stroke free status (QVSFS). - Able to give written informed consent. Exclusion Criteria: - QVSFS +ve. - Severe disability, life expectancy less than 6 months at enrollment. - Patients in whom MRI prolongation for 5 minutes can be harmful for the patient (Anesthesia, claustrophobia, sedation etc.). - Any clear contraindications to MRI, like pacemakers, metallic valves |
N/A
Country | Name | City | State |
---|---|---|---|
Pakistan | Aga Khan University | Karachi | Sindh |
Pakistan | Akuh,Duhs | Karachi | Sindh |
Lead Sponsor | Collaborator |
---|---|
Aga Khan University |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Distribution and Degree of Asymptomatic Intracranial Stenosis | This was defined as any artery (Internal Carotid Artery ICA, Middle Cerebral Artery MCA,Anterior Cerebral Artery ACA,Posterior Cerebral Artery PCA, Basilar Artery BA, and Vertebral Artery VA) having >25% stenosis on MRA. An internationally standardized ( WASID) equation was used to calculate the degree of stenosis. Percent stenosis= [1- (Dstenosis/D normal)*100], where D Stenosis is the diameter of the artery at the site of the most severe stenosis, and D normal= diameter of the proximal normal artery. |
MRA , Once , Over One Year | No |
Secondary | Associated Brain MRI Findings with Intracranial Stenosis | Brain volume reduction, Central and Peripheral Atrophy Periventricular Lucencies Silent Brain Infarcts | MRA Once , Over One Year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06058130 -
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
|
N/A | |
Completed |
NCT01838356 -
Intracranial Atherosclerosis and Depression After Coronary Artery Bypass Graft
|
N/A | |
Completed |
NCT05947994 -
Credo Stent in the Symptomatic Intracranial Stenosis
|
N/A | |
Terminated |
NCT03507374 -
PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
|
Early Phase 1 | |
Recruiting |
NCT02534545 -
Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS)
|
N/A | |
Recruiting |
NCT04010955 -
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
|
||
Not yet recruiting |
NCT05593224 -
The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Intracranial Atherosclerotic Stenosis
|
N/A | |
Recruiting |
NCT02719652 -
Vessel Wall and Perfusion Imaging in Intracranial Atherosclerosis
|
N/A | |
Active, not recruiting |
NCT04949880 -
A Single-Arm Trial of Neurovascular Drug-Eluting Balloon Dilatation Catheter Treating Symptomatic Intracranial Atherosclerotic Stenosis
|
N/A | |
Recruiting |
NCT06336174 -
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
|
||
Recruiting |
NCT04627870 -
ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis
|
N/A | |
Recruiting |
NCT05316311 -
A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis
|
N/A | |
Not yet recruiting |
NCT05757505 -
The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
|
N/A | |
Completed |
NCT01819597 -
Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis
|
N/A | |
Not yet recruiting |
NCT06331494 -
Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery
|
N/A | |
Recruiting |
NCT05550077 -
Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
|
||
Completed |
NCT05203887 -
Short- and Long-term Outcomes of Stenting for Symptomatic Intracranial Arterial Stenosis: a Cohort Study
|
||
Completed |
NCT04631055 -
ACOART Intracranial de Novo:DCB in the Treatment of Symptomatic Intracranial Atherosclerotic de Novo Stenosis
|
N/A | |
Completed |
NCT05631470 -
Diagnostic Accuracy for Hemodynamically ICAS of MR-FFR Comparing With Pressure-wire-based FFR.
|
||
Not yet recruiting |
NCT06453252 -
Predictors of Intracranial Atherosclerotic Disease in Posterior Circulation: a Cohort Study
|